This relationship may reflect the current understanding of TCL1 expression in CLL, where inter-patient variability remains the norm yet patients with the lowest TCL1 expression maintain favorable outcomes following chemoimmunotherapy41,42. Here, TCL1A is linked to B-cell chronic lymphocytic leukemia.